When you're vetting a provider, ask them directly about their pharmacy partners
Actual guidance based on body weight ranges, prior peptide experience, individual goals, and the tolerance patterns observed across hundreds of documented protocols
This can cause your healthcare practitioners to misdiagnose and mistreat their patients
Patients with severe liver or kidney issues, or those who experience significant side effects from either medication, should be cautious
People with pre-existing heart conditions If you have a history of atrial fibrillation, heart failure, or coronary artery disease, the heart rate increase from semaglutide deserves closer monitoring
Concomitant use of dipeptidyl-peptidase-4 inhibitors (DPP-4) is not recommended because they have a similar basis of action